| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/19/2008 | CA2257448C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 08/19/2008 | CA2120731C Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 08/16/2008 | CA2579119A1 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 08/14/2008 | WO2008098122A2 Method for treating allergic rhinitis without adverse effects |
| 08/14/2008 | WO2008097971A2 Methods for treating diseases of altered ige regulation |
| 08/14/2008 | WO2008097870A2 Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr) |
| 08/14/2008 | WO2008097866A2 Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells |
| 08/14/2008 | WO2008097824A2 Use of arsenic compounds for treatment of pain and inflammation |
| 08/14/2008 | WO2008096865A1 Therapeutic agent for disease induced by dysfunction or degeneration of organ |
| 08/14/2008 | WO2008096829A1 Tricyclic compounds |
| 08/14/2008 | WO2008096826A1 Prophylactic agent for autoimmune disease |
| 08/14/2008 | WO2008096769A1 Pharmaceutical compositions containing substituted cercosporamide derivatives |
| 08/14/2008 | WO2008096586A1 Novel methylated catechin and composition containing the same |
| 08/14/2008 | WO2008095908A1 1-benzenesulfonyl-1h-indole derivatives as inhibitors of ccr9 activity |
| 08/14/2008 | WO2008095679A1 Use of bartonella quintana derived lipopolysaccharide for the treatment of autoimmune, autoinflammatory or infectious diseases |
| 08/14/2008 | WO2008095293A1 [1,2,3] triazolyl substituted coumarins as inhibitors of leukotriene biosynthesis |
| 08/14/2008 | WO2008095292A1 [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis |
| 08/14/2008 | WO2008050363A8 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
| 08/14/2008 | US20080194797 Leucine-based motif and clostridial neurotoxins |
| 08/14/2008 | US20080194711 determining the level of expression of chemokine receptor (CX3CR1) genes or protein expression in natural killer cells; reduction of the relative expression is indicative of nervous system disorders; medical diagnosis |
| 08/14/2008 | US20080194676 Formulations for oral administration of cromolyn sodium |
| 08/14/2008 | US20080194670 Novel Thiophene Derivatives as Spingosine-1-Phosphate-1 Receptor Agonists |
| 08/14/2008 | US20080194652 Inactive isomer compositions for use as drug-resistance-reversal agents and in prophylactic treatment |
| 08/14/2008 | US20080194640 Optically Active Tetrahydronaphthalene Derivative |
| 08/14/2008 | US20080194638 Bioavailable formulations of heterocyclic compounds |
| 08/14/2008 | US20080194594 Hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant; kits |
| 08/14/2008 | US20080194583 Tubulin Inhibitors |
| 08/14/2008 | US20080194577 Antiallergens; asthma; autoimmune disease; pruritius; antiarthritic agents |
| 08/14/2008 | US20080194574 Pyrazine Derivatives As Effective Compounds Against Infectious Diseases |
| 08/14/2008 | US20080194553 compounds that are capable of increasing the serum level of insulin-like growth factor 1 (IGF-1) for the preparation of a therapeutical composition,in the form of a food supplement, for the treatment of subjects suffering from serious fatigue and exhausting symptoms, burn-out and chronic fatigue syndrome |
| 08/14/2008 | US20080194544 Also containing propylene glycol, hydroxypropyl methyl cellulose, a buffer, preservative and chelate compound; nose sprays; no bitter taste |
| 08/14/2008 | US20080194543 Immunosuppressive Ningalin Compounds |
| 08/14/2008 | US20080194526 Concentrate comprising a S1P receptor agonist selected from 2-amino-2-[2-(4-octylphenylethyl)]propane-1,3-diol, 2-amino-2-[4-(benzyloxyphenylthio)-2-chlorophenyl]ethyl-1,3-propane-diol, and 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}azetidine-3-carboxylic acid |
| 08/14/2008 | US20080194524 Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof |
| 08/14/2008 | US20080194517 Equine or canine immunomodulating composition and treatment method |
| 08/14/2008 | US20080194510 Substances, Compositions and Methods for Preventing and Treating Immune-Mediated Inflammatory Disorders |
| 08/14/2008 | US20080194474 Increasing the population of HSA+/Ly6C+ cells in bone marrow with Fms-like tyrosine kinase 3 ligand (Flt3-Ligand); preventing or delaying type I diabetes, rheumatoid arthritis, lupus, multiple sclerosis, psoriasis, scleroderma, inflammatory bowel diseases, or myasthenia gravis; bone marrow transplant |
| 08/14/2008 | US20080194469 Biodrug such as eptifibatide with blend of a hydrolyzable hydrophobic polymer containing diphenolic tyrosine monomer such as poly(desaminotyrosyltyrosine hexyl ester adipate (Poly(DTH adipate)), and another less hydrophobic hydrolyzable polymer that degrades to form acidic groups, releasing the biodrug |
| 08/14/2008 | US20080194462 Methods and Compositions for Treatment of Autoimmune Diseases |
| 08/14/2008 | US20080193550 conjugated linoleic acid; treat, prevent conditions associated with leukocyte infiltration, eosinophilia, IgE secretion, airway remodelling, bronchoconstriction, mucus hypersecretion, asthma; injection, ingestion, inhalation, topical |
| 08/14/2008 | US20080193549 Hoki Fish Liver Oil, Fractions Thereof And Therapeutic Uses |
| 08/14/2008 | US20080193488 Variant Polypeptide and Screening Assay |
| 08/14/2008 | US20080193487 Preparation for Vaccination, Vaccination Method and Use of a Vaccination Preparation |
| 08/14/2008 | US20080193485 Dairy products; vaccines; packages |
| 08/14/2008 | US20080193481 Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines |
| 08/14/2008 | US20080193474 Immunostimulatory Compositions |
| 08/14/2008 | US20080193473 Method for Preparing a Stable Immunogenic Product Comprising Antigenic Heterocomplexes of Tnf Alpha and a Carrier Protein |
| 08/14/2008 | US20080193472 Influenza vaccine formulation |
| 08/14/2008 | US20080193467 Dendritic cell potentiation |
| 08/14/2008 | US20080193450 Antibodies Against Candida Antigens |
| 08/14/2008 | US20080193447 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 08/14/2008 | US20080193439 Non-sensitive antigenic peptide derived from fc portion of the epsilon heavy chain of immunoglobulin-E for use in treatment and prevention of allergic disorders |
| 08/14/2008 | US20080193433 Water free of pathogens, pyrogens, heavy metals, and viruses, sprouted grain comprising digestive enzymes and undenatured whey protein; glutathione, triozyme; cancer, hepatitis and human immunodeficiency virus |
| 08/14/2008 | US20080193415 HSA-free formulations of interferon-beta |
| 08/14/2008 | US20080193414 Use of an Immunoglobulin Domain-Containing Cell Surface Recognition Molecule For Treating Diseases |
| 08/14/2008 | CA2845299A1 Use of arsenic compounds for treatment of pain and inflammation |
| 08/14/2008 | CA2715045A1 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr) |
| 08/14/2008 | CA2715044A1 Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells |
| 08/14/2008 | CA2677661A1 Tricyclic compounds |
| 08/14/2008 | CA2677388A1 Use of arsenic compounds for treatment of pain and inflammation |
| 08/14/2008 | CA2677310A1 Methods for treating diseases of altered ige regulation |
| 08/14/2008 | CA2677233A1 Prophylactic agent for autoimmune disease |
| 08/14/2008 | CA2676498A1 [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis |
| 08/14/2008 | CA2676145A1 1-benzenesulfonyl-1h-indole derivatives as inhibitors of ccr9 activity |
| 08/13/2008 | EP1956081A1 Method for detection of human precursor t cell and precursor b cell |
| 08/13/2008 | EP1956030A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/13/2008 | EP1956020A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity |
| 08/13/2008 | EP1956017A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and method of reducing TNF alpha levels |
| 08/13/2008 | EP1956009A1 Aromatic compound |
| 08/13/2008 | EP1955708A1 Novel memory ctl induction potentiator |
| 08/13/2008 | EP1954688A1 Novel thiophene derivatives |
| 08/13/2008 | EP1954320A2 Compositions comprising lipoxygenase inhibitors and cyclodextrin |
| 08/13/2008 | EP1954314A2 Preparation, comprising iron(iii) complex compounds and redox-active substances |
| 08/13/2008 | EP1954299A1 Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1 |
| 08/13/2008 | EP1954280A2 Compositions comprising a combination of ccr5 and cxcr4 antagonists |
| 08/13/2008 | EP1954245A2 Compositions of lipoxygenase inhibitors |
| 08/13/2008 | EP1565183B1 Rapamycin and il-10 for the treatment of autoimmune diseases |
| 08/13/2008 | EP1541558B1 Heterocyclic compounds having hiv integrase inhibitory activity |
| 08/13/2008 | EP1539714B1 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 08/13/2008 | EP1501803B1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 08/13/2008 | EP1501566B1 Medical products comprising a haemocompatible coating, production and use thereof |
| 08/13/2008 | EP1489088B1 Novel alpha-amino-n-(diaminophosphinyl)lactam derivative |
| 08/13/2008 | EP1467979B1 Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function |
| 08/13/2008 | EP1389098B1 Delivery of antipsychotics through an inhalation route |
| 08/13/2008 | EP1389097B1 Delivery of compounds for the treatment of parkinsons through an inhalation route |
| 08/13/2008 | EP1386923B1 Novel adenine derivatives |
| 08/13/2008 | EP1322309B1 High affinity small molecule c5a receptor modulators |
| 08/13/2008 | EP1274453B1 Recombinant bcg vaccines against intracellular pathogens and methods for use |
| 08/13/2008 | EP1251835B1 Closure of bacterial ghosts |
| 08/13/2008 | EP1173549B1 Use of cytokines and mitogens to inhibit pathological immune responses |
| 08/13/2008 | EP1154759B1 Dispersible concentrate for the delivery of cyclosporin |
| 08/13/2008 | EP1064308B1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 08/13/2008 | EP0835133B1 Recombinant poxvirus-rabies compositions and combination compositions and uses |
| 08/13/2008 | CN101243105A Methods and compositions for targeting IFNAR2 |
| 08/13/2008 | CN101243102A Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation |
| 08/13/2008 | CN101243086A Indoli zine derivatives and their use as CRTH2 antagonists |
| 08/13/2008 | CN101243072A Piperidine derivatives useful as histamine H3 antagonists |
| 08/13/2008 | CN101243053A N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents |
| 08/13/2008 | CN101242849A Promoter of differentiation and keratinization of epidermic cell and functional beverage/food for promotion of keratinization of epidermis |
| 08/13/2008 | CN101240000A Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |